JP Morgan Initiates Albany Molecular Research At Overweight
September 09, 2014 at 07:34 AM EDT
Analysts at JP Morgan initiated coverage on shares of Albany Molecular Research (NASDAQ: AMRI) with a Overweight rating. The target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.